DXC Know-how has accomplished the sale of its healthcare supplier software program enterprise to the Dedalus Group.
The deal was initially introduced in July 2020 and DXC stated it expects to obtain round £350million ($450million) from the deal.
Mike Salvino, president and CEO at DXC, stated: “The completion of the sale of our healthcare supplier software program enterprise strengthens our steadiness sheet and unlocks new worth for our stakeholders.
“I wish to thank our people who find themselves shifting on to the Dedalus Group for his or her dedication and contributions through the years and for his or her deal with our prospects throughout this course of.”
The sale will propel European well being IT and diagnostics specialist Dedalus into a number one market share place within the NHS as a consequence of DXC Know-how’s massive legacy set up base that provides it a footprint in lots of NHS trusts, a mix of Lorenzo and older iSoft software program.
Andrea Fiumicelli, CEO of Dedalus Group, added: “Dedalus’ imaginative and prescient is for a digitally enabled healthcare ecosystem the place all stakeholders actively collaborate throughout the continuum of care to enhance every citizen’s well being outcomes.
“The acquisition by Dedalus is on par with our progress initiative technique that started 4 years in the past. Our expanded software program options allow the combination of processes, workflows and functions with the intention to enhance healthcare outcomes for every particular person and for the inhabitants as an entire. On the core of our enterprise is a continuing focus and dedication to information safety and to create and ship innovation at scale.”